Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-06-21

Clinical Trial Update: Pro Osteon Bone Void Filler Study

View source ↗

Summary

A clinical trial of Pro Osteon Bone Void Filler sponsored by Zimmer Biomet has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pro Osteon Bone Void Filler

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Revision Arthroplasty | Status: WITHDRAWN